Retroperitoneal Doege-Potter syndrome with intraoperative blood glucose monitoring.

Autor: Nagasaka H; Department of Urology Kanagawa Cancer Center Yokohama Japan., Suzuki T; Department of Urology Kanagawa Cancer Center Yokohama Japan., Kondo T; Department of Urology Kanagawa Cancer Center Yokohama Japan., Koizumi M; Department of Urology Kanagawa Cancer Center Yokohama Japan., Terao H; Department of Urology Kanagawa Cancer Center Yokohama Japan., Murohashi Y; Department of Diabetes Endocrinology Kanagawa Cancer Center Yokohama Japan., Okubo Y; Department of Pathology Kanagawa Cancer Center Yokohama Japan., Yokose T; Department of Pathology Kanagawa Cancer Center Yokohama Japan., Kishida T; Department of Urology Kanagawa Cancer Center Yokohama Japan.
Jazyk: angličtina
Zdroj: IJU case reports [IJU Case Rep] 2024 Jul 30; Vol. 7 (5), pp. 391-394. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).
DOI: 10.1002/iju5.12765
Abstrakt: Background: Doege-Potter syndrome, characterized by solitary fibrous tumors and non-islet cell tumor hypoglycemia, is rare. Here, we report a case of Doege-Potter syndrome in which retroperitoneal tumor resection was performed with continuous intraoperative blood glucose monitoring.
Case Presentation: A 37-year-old man presented with hypoglycemia-related symptoms, and a 10 × 12 × 9 cm tumor was found in his right kidney. Following tumor resection, insulin secretory abnormalities improved, and intraoperative blood glucose monitoring showed no hypoglycemic events. High levels of insulin-like growth factor-II confirmed the diagnosis of an insulin-like growth factor-II-producing tumor with non-islet cell tumor hypoglycemia. Postoperative serum insulin-like growth factor-II levels normalized, with no recurrence observed over 3 years.
Conclusions: This case highlights the rarity of primary retroperitoneal Doege-Potter syndrome, emphasizes the safety of intraoperative blood glucose levels during surgery, and suggests rapid recovery of insulin secretion postoperatively.
Competing Interests: The authors have no conflicts of interest to declare.
(© 2024 The Author(s). IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.)
Databáze: MEDLINE
Externí odkaz: